In this webinar, we discuss how to use systems to model metastatic progression, evaluate therapeutics and improve our understanding of the bidirectional crosstalk that occurs between host tissue cells and the metastatic cancer cells.
Research Assistant Professor
University of Pittsburgh
Watch this webinar to learn:
Metastatic disease is the leading cause of mortality in patients with solid tumors. Despite decades of research, we only partially understand the underlying cellular and molecular mechanisms.
This gap in knowledge represents a significant barrier for the prevention and treatment of metastasis. In part, a lack of relevant accessible model systems capable of capturing the complexities of metastatic disease progression has hindered our progress. As a result, researchers are turning towards tissue engineered ex vivo biomimetic microphysiological systems.
Join industry leaders in a series of webinars focused on Organ-On-Chip technology
Using Microfluidics To Mimic Blood Flow in Single- and Multi-Organ-on-a-Chip . . .Watch webinar